Luca Voltolini
Azienda Ospedaliero-Universitaria Careggi
ORCID: 0000-0002-2818-859XAlso affiliated with University of Florence
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies”.
Navid Sobhani, Robert Chapman, Stefan Bagby, Carlotta Bortoletti, Mirko Traversini +5 more
Pierre‐Emmanuel Falcoz, Bernhard Moser, Dirk Van Raemdonck, Andrea Billè, Alper Toker +44 more
Pierre‐Emmanuel Falcoz, Bernhard Moser, Dirk Van Raemdonck, Andrea Billè, Alper Toker +45 more